.

Make Better Decisions

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Novartis
Deloitte
Merck
UBS
Argus Health
Covington
Queensland Health
Chinese Patent Office
Dow

Generated: November 23, 2017

DrugPatentWatch Database Preview

CARDENE Drug Profile

« Back to Dashboard

What is the patent landscape for Cardene, and when can generic versions of Cardene launch?

Cardene is a drug marketed by Chiesi Usa Inc and is included in three NDAs. There are four patents protecting this drug and five Paragraph IV challenges.

The generic ingredient in CARDENE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chiesi Usa Inc
CARDENE
nicardipine hydrochloride
INJECTABLE;INJECTION019734-001Jan 30, 1992APRXYesYes► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-005Nov 7, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-004Nov 7, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CARDENE IN 0.83% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-004Nov 7, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Chiesi Usa Inc
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-002Jul 31, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Chiesi Usa Inc
CARDENE SR
nicardipine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL020005-001Feb 21, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Chiesi Usa Inc
CARDENE IN 0.86% SODIUM CHLORIDE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-003Jul 31, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Chiesi Usa Inc
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-005Nov 7, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
Chiesi Usa Inc
CARDENE IN 5.0% DEXTROSE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-005Nov 7, 2008RXYesYes► Subscribe► Subscribe ► Subscribe
Chiesi Usa Inc
CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
nicardipine hydrochloride
INJECTABLE;INTRAVENOUS019734-002Jul 31, 2008RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CARDENE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Chiesi Usa Inc
CARDENE
nicardipine hydrochloride
INJECTABLE;INJECTION019734-001Jan 30, 1992► Subscribe► Subscribe
Chiesi Usa Inc
CARDENE
nicardipine hydrochloride
CAPSULE;ORAL019488-001Dec 21, 1988► Subscribe► Subscribe
Chiesi Usa Inc
CARDENE
nicardipine hydrochloride
INJECTABLE;INJECTION019734-001Jan 30, 1992► Subscribe► Subscribe
Chiesi Usa Inc
CARDENE
nicardipine hydrochloride
INJECTABLE;INJECTION019734-001Jan 30, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CARDENE

Drugname Dosage Strength RLD Submissiondate
nicardipine hydrochlorideInjection0.1 mg/mL, 200 mL and0.2mg/mL, 200 mLCardene 0.83% Sodium Chloride in plastic container6/20/2013
nicardipine hydrochlorideInjection0.1 mg/mL, 200 mL and0.2mg/mL, 200 mLCardene in 0.86% Sodium Chloride in plas6/20/2013
nicardipine hydrochlorideInjection0.1 mg/mL, 200 mL and0.2mg/mL, 200 mLCardene 0.83% Sodium Chloride in plastic6/20/2013
nicardipine hydrochlorideInjection0.1 mg/mL, 200 mL and0.2mg/mL, 200 mLCardene in 0.86% Sodium Chloride in plastic container6/20/2013
nicardipine hydrochlorideInjection2.5 mg/mL, 10 mL AmpoulesCardene12/27/2006
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Daiichi Sankyo
AstraZeneca
Chubb
Teva
Julphar
McKinsey
Cerilliant
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot